OPTFSNA
TEVA icon

Old Point Trust & Financial Services N A’s Teva Pharmaceuticals TEVA Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-500
Closed -$7.05K – 517
2024
Q1 		$7.05K Buy
+500
New +$6.3K ﹤0.01% 316
2022
Q3 		– Sell
-11,650
Closed -$88K – 79
2022
Q2 		$88K Sell
11,650
-28,900
-71% -$252K 0.04% 78
2022
Q1 		$381K Sell
40,550
-1,400
-3% -$11.7K 0.16% 61
2021
Q4 		$336K Sell
41,950
-600
-1% -$5.42K 0.14% 63
2021
Q3 		$414K Sell
42,550
-6,100
-13% -$57.1K 0.18% 57
2021
Q2 		$482K Sell
48,650
-3,500
-7% -$37K 0.21% 57
2021
Q1 		$602K Buy
52,150
+7,400
+17% +$84.9K 0.28% 52
2020
Q4 		$432K Sell
44,750
-500
-1% -$4.79K 0.22% 53
2020
Q3 		$408K Hold
45,250
– – 0.22% 55
2020
Q2 		$558K Buy
45,250
+1,500
+3% +$17K 0.31% 53
2020
Q1 		$393K Sell
43,750
-4,250
-9% -$43.5K 0.25% 53
2019
Q4 		$470K Sell
48,000
-9,900
-17% -$88.4K 0.22% 59
2019
Q3 		$398K Sell
57,900
-2,305
-4% -$17.7K 0.19% 61
2019
Q2 		$556K Sell
60,205
-900
-1% -$10.9K 0.28% 56
2019
Q1 		$958K Buy
61,105
+1,200
+2% +$21.2K 0.5% 49
2018
Q4 		$923K Buy
59,905
+5,000
+9% +$103K 0.54% 47
2018
Q3 		$1.18M Buy
54,905
+6,852
+14% +$159K 0.61% 46
2018
Q2 		$1.17M Buy
48,053
+5,000
+12% +$102K 0.64% 46
2018
Q1 		$736K Sell
43,053
-6,350
-13% -$124K 0.42% 53
2017
Q4 		$937K Sell
49,403
-4,102
-8% -$61.7K 0.51% 52
2017
Q3 		$942K Buy
53,505
+5,000
+10% +$113K 0.53% 50
2017
Q2 		$1.61M Sell
48,505
-100
-0.2% -$3.1K 0.93% 38
2017
Q1 		$1.56M Buy
48,605
+4,200
+9% +$143K 0.9% 39
2016
Q4 		$1.61M Sell
44,405
-950
-2% -$37.9K 0.96% 37
2016
Q3 		$2.09M Buy
45,355
+150
+0.3% +$7.83K 1.28% 29
2016
Q2 		$2.27M Sell
45,205
-850
-2% -$45.3K 1.41% 29
2016
Q1 		$2.46M Sell
46,055
-50
-0.1% -$2.93K 1.54% 27
2015
Q4 		$3.03M Buy
46,105
+1,900
+4% +$117K 1.97% 23
2015
Q3 		$2.5M Sell
44,205
-550
-1% -$35.7K 1.77% 23
2015
Q2 		$2.65M Buy
44,755
+1,200
+3% +$74K 1.72% 26
2015
Q1 		$2.71M Buy
43,555
+5
+0% +$291 1.75% 26
2014
Q4 		$2.5M Buy
43,550
+1,300
+3% +$72.4K 1.51% 28
2014
Q3 		$2.27M Buy
42,250
+3,950
+10% +$209K 1.36% 28
2014
Q2 		$2.01M Buy
38,300
+1,400
+4% +$71.6K 1.2% 31
2014
Q1 		$1.95M Buy
+36,900
New +$1.71M 1.22% 31

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Old Point Trust & Financial Services N A's TEVA Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 500 shares — an estimated $7.05K sold.

Old Point Trust & Financial Services N A first reported a position in TEVA in Q1 2014 and held it in 35 quarters. The position peaked at $3.03M in Q4 2015. 533 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 500 Teva Pharmaceuticals shares in Q2 2024, an estimated $7.05K.
  • Old Point Trust & Financial Services N A first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 35 quarters.
  • Old Point Trust & Financial Services N A's Teva Pharmaceuticals position peaked at $3.03M in Q4 2015.
  • 533 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.